A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.

• المؤلفون الرئيسيون: Courtney Woolsey (مؤلف), Robert W Cross (مؤلف), Krystle N Agans (مؤلف), Viktoriya Borisevich (مؤلف), Daniel J Deer (مؤلف), Joan B Geisbert (مؤلف), Cheryl Gerardi (مؤلف), Theresa E Latham (مؤلف), Karla A Fenton (مؤلف), Michael A Egan (مؤلف), John H Eldridge (مؤلف), Thomas W Geisbert (مؤلف), Demetrius Matassov (مؤلف)
• التنسيق: كتاب
• منشور في: Public Library of Science (PLoS), 2022-05-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

<h4>Background</h4>Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public health as demonstrated by its high associated mortality rate (23-90%) and recent emergence in West Africa for the first time. Although a recombinant vesicular stomatitis virus (rVSV)-based v...